Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss treatment strategies for hyponatremia patients with cirrhosis and ascites
- Recall data from studies investigating the treatment and prevention of hepatocellular carcinoma
- Summarize findings from studies evaluating the accuracy of radiologic staging and imaging of hepatocellular carcinoma
- Describe results from studies investigating the optimal time to initiate interferon-based therapy in liver transplant recipients with hepatitis C virus recurrence
- Explain outcomes of studies investigating the use of insulin-sensitizing agents in the treatment of patients with fatty liver disease
Topics covered include:
- Introduction
- Managing Hyponatremia in Patients With Cirrhosis and Ascites
- Peginterferon Maintenance Treatment for the Prevention of Hepatocellular Carcinoma in a Nonresponder Population
- Role of Regulatory T Cells in Anti-HCC Immunity
- Mathematical Models to Predict Risk of HCC Based on Data From the REVEAL Cohort
- Accuracy of Radiologic Staging of HCC
- Accuracy of Radiologic Imaging of HCC
- When to Initiate Antiviral Treatment of HCV Recurrence Following Liver Transplantation
- Treatment With Recombinant Factor VIIa for Bleeding Complications in Cirrhotics
- Improvements in Survival for Acute Liver Failure Patients
- Use of Insulin-Sensitizing Agents to Improve Liver Histology in NAFLD
- Use of Liver Elastography for Staging Liver Fibrosis
- Use of Liver Stiffness Measurement for Identifying Portal Hypertension
- Use of Magnetic Resonance Elastography for Staging Liver Fibrosis
- Predictors of a Response to UDCA Therapy for Primary Biliary Cirrhosis